UnknownNot Applicable

Ultrasound-Guided Aspiration of PTA vs Conventional Landmark Technique - a RCT

Denmark88 participantsStarted 2018-11-26

Plain-language summary

The study is a prospective randomized controlled trial conducted at two different centers at the Department of ORL - Head \& Neck Surgery, Odense University Hospital and the Department of Otorhinolaryngology, Head and Neck Surgery \& Audiology, Rigshospitalet. The research question is: In a group of patients referred to an otolaryngology department with objective findings of peritonsillar abscess, what are the effects of using intraoral ultrasound to diagnose and guide needle aspiration compared to the traditional landmark-based technique, when measured by the number of performed needle aspirations, procedure-related pain and days on sick leave? The secondary outcomes measured are * Number of hospitalization days * Number of Quincy tonsillectomies * Number of visits to an outpatient clinic * Patient-reported outcome (measured using an 11-point numeric rating scale)

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Trismus
. Unilateral tonsillar/peritonsillar swelling

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

needle aspirations

Timeframe: From date of randomization until the date of full recovery from the treated peritonsilar infection, assessed up to 1 months.

proportion of succesfull needle aspirations

Timeframe: From date of randomization until the date of full recovery from the treated peritonsilar infection, assessed up to 1 months.

days on sick leave

Timeframe: From date of randomization until the date of full recovery from the treated peritonsilar infection, assessed up to 1 months.

Trial details

NCT IDNCT03824288

SponsorTobias Todsen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-08-30

Contact for this trial

Tobias Todsen, MD, PhD

51847468 tobias.todsen@regionh.dk

View on ClinicalTrials.gov More Peritonsillar Abscess trials

Plain-language summary

What they're measuring

needle aspirations

Timeframe: From date of randomization until the date of full recovery from the treated peritonsilar infection, assessed up to 1 months.

proportion of succesfull needle aspirations

Timeframe: From date of randomization until the date of full recovery from the treated peritonsilar infection, assessed up to 1 months.

days on sick leave

Timeframe: From date of randomization until the date of full recovery from the treated peritonsilar infection, assessed up to 1 months.